Showing results (151-160 of 219) with videos related to

Sort By:
Pageof 22
Hepatology International|March 6, 2019
Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patientsBenjamin Emmanuel, Samer S El-Kamary, Laurence S Magder, et al.
The Journal of Infectious Diseases|March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2aJonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Springerplus|November 14, 2014
HCC surveillance results in earlier HCC detection: results from an Indian cohortAnita Kohli, Allison A Murphy, Chirdeep Agarwal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic BlockadeKenneth E Sherman, Enass Abdel-Hameed, Susan D Rouster, et al.
AIDS Research and Human Retroviruses|March 15, 2016
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and RibavirinTess Petersen, Yu-Jin Lee, Anu Osinusi, et al.
Journal of Viral Hepatitis|June 11, 2026
Cardiac MRI Identifies Subclinical Myocardial Tissue Abnormalities in Individuals With Hepatitis C Regardless of Myocardial Damage Markers or Fibrosis StageAaron D'Amore, Arlene Sirajuddin, Nivya George, et al.
Scientific Reports|April 2, 2020
Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patientsJin Hyang Kim, Alip Ghosh, Natarajan Ayithan, et al.
The Journal of Infectious Diseases|August 6, 2010
Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patientsPeter D Burbelo, Joseph A Kovacs, Kathryn H Ching, et al.
Proteomics. Clinical Applications|July 31, 2018
Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient PopulationsSusanna Naggie, Meredith Clement, Sam Lusk, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2009
Altered regulation of extrinsic apoptosis pathway in HCV-infected HCC cells enhances susceptibility to mapatumumab-induced apoptosisXiaozhen Zhang, Astrid C Frank, Christine M Gille, et al.
Pageof 22